Biotech Values

[ghmm]

ONCE:

I closed out my short position and sold my puts today. I don't think the reaction was strong enough but I am not good at predicting short-term moves. I think when they present the Hemophilia A data it could bump down a bit more as they gave limited data and spoke in generalities I suspect highlighting the positive aspects. Further, I would be concerned with a couple things:
1-Its not clear a different steroid protocol will stop the immune response on all patients or may lead to lower overall factor levels.
2-The president suspected they may be seeing this with higher doses and that is why didn't see it in their B program (when asked about earlier steroid use)... my reaction was what happens when in the B program when you go to a 100+ patients I suspect could see some similar issues (though perhaps at much lower scale).

Katherine High came across so bad that I decided not to consider a long position while she is at the company. Here are a couple things
https://twitter.com/MauriceOnTW/status/1026925366349324288